Sonoma Pharmaceuticals
SNOA
12 hedge funds and large institutions have $97.3K invested in Sonoma Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0.04% less ownership
Funds ownership: 0.16% → 0.12% (-0.04%)
20% less funds holding
Funds holding: 15 → 12 (-3)
44% less capital invested
Capital invested by funds: $175K → $97.3K (-$77.7K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$938 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$16K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$13.2K |
| 3 |
Renaissance Technologies
New York
|
-$8.01K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$430 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$156 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $29.7K | -$13.2K | -676 | -26% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $27.6K | -$430 | -22 | -1% |
|
3
State Street
Boston,
Massachusetts
| $18.8K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $11K | -$8.01K | -410 | -37% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $7.36K | +$938 | +48 | +11% |
|
6
BlackRock
New York
| $2.22K | – | – | – |
|
7
US Bancorp
Minneapolis,
Minnesota
| $386 | – | – | – |
|
8
Morgan Stanley
New York
| $66 | – | – | – |
|
|
AF
9
Allworth Financial
Folsom,
California
| $51 | – | – | – |
|
|
10
Osaic Holdings
Scottsdale,
Arizona
| $38 | -$156 | -8 | -73% |
|
11
Bank of America
Charlotte,
North Carolina
| $34 | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $29 | – | – | – |
|
|
VF
13
Virtu Financial
New York
| – | -$16K | -737 | Closed |
|
|
GI
14
Gradient Investments
Arden Hills,
Minnesota
| – | -$33 | -2 | Closed |
|
|
NC
15
NewSquare Capital
Newtown Square,
Pennsylvania
| – | -$11 | -1 | Closed |
|
SNOA Hedge Fund Activity: Q3 2023 in Review
12 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2023, worth a combined $97.3K — down 44% from $175K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SNOA and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $938. The largest seller was Virtu Financial, exiting entirely with an estimated $16K sold.
- 12 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2023, down from 15 in Q2 2023.
- Funds reported $97.3K of Sonoma Pharmaceuticals stock for Q3 2023, down 44% quarter-over-quarter.
- 0 funds opened new Sonoma Pharmaceuticals positions in Q3 2023 and 3 closed out, a net change of -3 holders.
- The largest Sonoma Pharmaceuticals buyer in Q3 2023 was Tower Research Capital (TRC), an estimated $938 added.
- The largest Sonoma Pharmaceuticals seller in Q3 2023 was Virtu Financial, an estimated $16K sold.
Based on aggregated 13F filings for Q3 2023.